Therapeutic Properties of Highly Selective β-blockers With or Without Additional Vasodilator Properties: Focus on Bisoprolol and Nebivolol in Patients With Cardiovascular Disease

Bisoprolol and nebivolol are highly selective β(1)-adrenoceptor antagonists, with clinical indications in many countries within the management of heart failure with reduced left ventricular ejection fraction (HFrEF), ischaemic heart disease (IHD), and hypertension. Nebivolol has additional vasodilat...

Descripción completa

Detalles Bibliográficos
Autores principales: AlHabeeb, Waleed, Mrabeti, Sanaa, Abdelsalam, Ahmed Adel Ibrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519665/
https://www.ncbi.nlm.nih.gov/pubmed/34106365
http://dx.doi.org/10.1007/s10557-021-07205-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519665/
https://www.ncbi.nlm.nih.gov/pubmed/34106365
http://dx.doi.org/10.1007/s10557-021-07205-y

Ejemplares similares